{
    "clinical_study": {
        "@rank": "35341", 
        "acronym": "TRANEXFER", 
        "arm_group": [
            {
                "arm_group_label": "Tranexamic acid", 
                "arm_group_type": "Experimental", 
                "description": "Tranexamic acid, 1g intra-articular before closing the surgery wound"
            }, 
            {
                "arm_group_label": "Fibrin glue", 
                "arm_group_type": "Experimental", 
                "description": "One intra-articular dose of fibrin glue (Evicel 5mL) before closing the wound surgery,"
            }, 
            {
                "arm_group_label": "Usual hemostasia", 
                "arm_group_type": "Active Comparator", 
                "description": "Electrocauterization"
            }
        ], 
        "brief_summary": {
            "textblock": "The main hypothesis of this clinical trial is that the use of intra-articular tranexamic\n      acid and the fibrin glue plus usual hemostasis will reduce at least a 25% the postoperative\n      blood loss with respect to usual hemostasis in patients undergoing subcapital femoral\n      fractures."
        }, 
        "brief_title": "Prevention of Postoperative Bleeding in Subcapital Femoral Fractures: a Multicenter, Randomized, Controlled, Parallel Clinical Trial", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hip Fracture", 
            "Blood Loss"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Femoral Fractures", 
                "Fractures, Bone", 
                "Hemorrhage", 
                "Hip Fractures", 
                "Postoperative Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients over 18 years\n\n          -  Patients with unilateral subcapital femoral fracture\n\n          -  Patients requiring hip replacement (total or partial)\n\n          -  Signed informed consent from the patient or legal representative\n\n        Exclusion Criteria:\n\n          -  Known allergy to fibrin glue and tranexamic acid\n\n          -  Multiple fractures\n\n          -  Pathological fractures\n\n          -  Contraceptives or estrogen therapy\n\n          -  Use of blood salvage during surgery\n\n          -  History compatible with thromboembolic disease:\n\n               -  Cerebral vascular accident\n\n               -  Ischemic heart disease (myocardial infarction, angina )\n\n               -  Deep vein thrombosis\n\n               -  Pulmonary Embolism\n\n               -  Peripheral arterial vasculopathy\n\n               -  Patients with thrombogenic arrhythmias\n\n               -  Patients with cardiovascular stents\n\n               -  Prothrombotic alterations in coagulation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "165", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02150720", 
            "org_study_id": "IIBSP-FAT-2011-103", 
            "secondary_id": [
                "EC11-341", 
                "2011-006278-15", 
                "SA/12/AYU/456"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Tranexamic acid", 
                "description": "1g intra-articular before closing the wound surgery", 
                "intervention_name": "Tranexamic Acid", 
                "intervention_type": "Drug", 
                "other_name": "Amchafibrin"
            }, 
            {
                "arm_group_label": "Fibrin glue", 
                "description": "5mL intra-articular before closing the wound surgery", 
                "intervention_name": "Fibrin glue", 
                "intervention_type": "Drug", 
                "other_name": "Evicel"
            }, 
            {
                "arm_group_label": [
                    "Tranexamic acid", 
                    "Fibrin glue", 
                    "Usual hemostasia"
                ], 
                "description": "Coagulation blood from vessels by means of a electrocautery.", 
                "intervention_name": "Electrocauterization", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fibrin Tissue Adhesive", 
                "Tranexamic Acid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hip fractures", 
            "Clinical Trial", 
            "Randomized", 
            "Fibrin glue", 
            "Tranexamic acid", 
            "Blood loss"
        ], 
        "lastchanged_date": "May 29, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "JA Hern\u00e1ndez Hermoso, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Badalona", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08916"
                    }, 
                    "name": "Hospital Germans Trias i Pujol de Badalona"
                }, 
                "investigator": {
                    "last_name": "JA Hern\u00e1ndez Hermoso, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "M. Salom\u00f3, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Sabadell", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08208"
                    }, 
                    "name": "Parc Taul\u00ed"
                }, 
                "investigator": {
                    "last_name": "M. Salom\u00f3, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "P. Castill\u00f3n, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Terrassa", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08221"
                    }, 
                    "name": "Hospital Universitari M\u00fatua Terrassa"
                }, 
                "investigator": {
                    "last_name": "P. Castill\u00f3n, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "JA Mora Guix, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Terrassa", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08227"
                    }, 
                    "name": "Hospital Universitari Terrassa-Consorci Sanitari de Terrassa"
                }, 
                "investigator": {
                    "last_name": "JA Mora Guix, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "M Jordan, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08025"
                    }, 
                    "name": "Hospital de la Santa Creu i Sant Pau"
                }, 
                "investigator": {
                    "last_name": "M. Jordan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinic"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "3", 
        "official_title": "Prevention of Postoperative Bleeding in Femoral Fractures: a Multicenter, Randomized, Controlled, Parallel Clinical Trial to Assess the Efficacy of Tranexamic Acid and Fibrin Glue", 
        "overall_contact": {
            "email": "mmartinezz@santpau.cat", 
            "last_name": "MJ Martinez-Zapata, MD, PhD", 
            "phone": "34 93 553 78 08"
        }, 
        "overall_official": {
            "affiliation": "Iberoamerican Cochrane Centre. Research Institut Hospital de la Santa Creu i Sant Pau. IIB Sant Pau", 
            "last_name": "MJ Mart\u00ednez-Zapata, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The blood lost from the wound will be collected by a drainage system during the first 24 hours postoperatively.", 
            "measure": "Blood loss (ml) after surgery", 
            "safety_issue": "No", 
            "time_frame": "The first postoperative 24h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02150720"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The hidden blood loss is the total blood loss calculated by the formula of Nadler minus the blood loss by drain.", 
                "measure": "Hidden blood loss", 
                "safety_issue": "No", 
                "time_frame": "The first postoperative five days"
            }, 
            {
                "measure": "Proportion of patients requiring blood transfusion", 
                "safety_issue": "No", 
                "time_frame": "The first  postoperative ten days"
            }, 
            {
                "measure": "Units of blood transfused", 
                "safety_issue": "No", 
                "time_frame": "The first  postoperative ten days"
            }, 
            {
                "measure": "Proportion of patients with wound infection", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Proportion of patients with wound dehiscence", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Deep venous thrombosis", 
                "safety_issue": "Yes", 
                "time_frame": "The first  postoperative ten days"
            }, 
            {
                "description": "Time from hip surgery until hospital discharge", 
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "The first  postoperative ten days"
            }, 
            {
                "measure": "Quality of life measured with the generic EQ-5D -5L", 
                "safety_issue": "No", 
                "time_frame": "Preoperatively, at 5 days postoperatively , 1-2, 6 and 12 months postoperative follow-up"
            }, 
            {
                "measure": "Mortality", 
                "safety_issue": "Yes", 
                "time_frame": "During the 12 month of follow-up after surgery"
            }, 
            {
                "measure": "Direct cost", 
                "safety_issue": "No", 
                "time_frame": "During the first postoperative month"
            }
        ], 
        "source": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}